Dry eye disease affects millions of patients, yet the growing list of treatment options can make decision-making feel more complicated than ever. Treating dry eyes requires understanding not just what options are available, but where each one fits into therapy.
In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, walks through the causes of dry eye disease and breaks down today’s treatment landscape, from OTC artificial tears to prescription options like cyclosporine, lifitegrast, and newer therapies. She highlights how these medications work, where they fit in therapy, and practical counseling tips to help patients get relief.
This is an excerpt from our November 2025 Pharmacy Essential Updates continuing education webinar series.
******
CE Information:
TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose.
******
Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.
Use code cc1026 at checkout for 10% off a new or upgraded subscription.
🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.
Email us: ContactUs@trchealthcare.com.
The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
Learn more about our product offerings at trchealthcare.com.
